From: Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis
Analysis | Method | Cost | Δ cost | Cases w/o CP | Δ cases w/o CP | ICER | Status |
---|---|---|---|---|---|---|---|
Health system perspective | MgSO4 | $2,055 | $425 | 0.96 | 0.01 | $28,755 | a |
No MgSO4 | $1,630 | 0.95 | |||||
Societal perspective | MgSO4 | $61,028 | -$22,109 | 0.96 | 0.01 | -$1,494,500 | Dominant |
No MgSO4 | $83,137 | 0.95 |